quantisnow
FeedTopReportsPricing
⌘K
Live feed
00:15:29·907d
SECFiling
Calyxt Inc. logo

SEC Form EFFECT filed by Calyxt Inc.

CLXT· Calyxt Inc.
Industrials
Original source

Companies

  • CLXT
    Calyxt Inc.
    Industrials

Recent analyst ratings

  • Mar 4UpdateCanaccord Genuity$4.00
  • Nov 2UpdateROTH Capital$10.00

Related

  • PR451d
    Totus Medicines Appoints Simon Harnest, MSc, BSc, as Chief Financial Officer
  • 13D/G805d
    SEC Form SC 13G/A filed by Calyxt Inc. (Amendment)
  • SEC835d
    Calyxt Inc. filed SEC Form 8-K: Regulation FD Disclosure, Other Events, Financial Statements and Exhibits
  • INSIDER841d
    Riggs Rory B converted options into 1,500,000 shares and acquired 1,505,967 units of Class B Common Stock, increasing direct ownership by 128% to 3,103,788 units (SEC Form 4)
  • SEC843d
    Calyxt Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits
  • SEC843d
    SEC Form 424B5 filed by Calyxt Inc.
  • SEC846d
    Calyxt Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits
  • INSIDER861d
    Riggs Rory B disposed of 39,476 shares and bought $5,470,992 worth of shares (517,107 units at $10.58), increasing direct ownership by 47% to 1,622,495 units (SEC Form 4)
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022